S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

OTLK Outlook Therapeutics Inc

2.06

0.00 (0.00%)

Feb 02 2025 - Closed

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Outlook Therapeutics Charts.

Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Outlook Therapeutics Charts.

Outlook Therapeutics Inc News

Form PRE 14A - Other preliminary proxy statements
Friday 31 January 2025 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 31 January 2025 (2 days ago) • Edgar (US Regulatory)

Outlook Therapeutics® Appoints Faisal G. Sukhtian as Chairman of the Board of Directors
Friday 31 January 2025 (3 days ago) • GlobeNewswire Inc.

Form D - Notice of Exempt Offering of Securities
Monday 27 January 2025 (6 days ago) • Edgar (US Regulatory)

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Thursday 23 January 2025 (1 week ago) • Edgar (US Regulatory)

Outlook Therapeutics® Announces Presentation of Efficacy and Safety Results from NORSE EIGHT Clinical Trial Evaluating ONS-5010 for the Treatment of Wet AMD
Thursday 23 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Wednesday 22 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 22 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Outlook Therapeutics® to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
Wednesday 22 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 16 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial
Thursday 16 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Outlook Therapeutics® Participates in Virtual Investor “What This Means” Segment
Wednesday 8 January 2025 (4 weeks ago) • GlobeNewswire Inc.

More Outlook Therapeutics Inc News Articles

Liquidmetal Technologies (QB)

RespireRx Pharmaceuticals (CE)

Moon Equity (PK)

Bioelectronics (PK)

Lightwave Logic

Northwest Biotherapeutics (QB)

Anavex Life Sciences

Valiant Eagle (PK)

Intergrated Cannabis Sol... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions